MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces Fourth Quarter Results; Announces Management Additions
EverGen Infrastructure reported their Q4 ‘21 quarterly results on April 21, 2022 The company reported 4Q21 revenues of CAD $2.693 million, +39% QoQ EverGen simultaneously reported that their 4Q21 EBITDA was impacted by the flooding…
-
Golden Matrix Group Inc. (NASDAQ: GMGI) Records 14th Profitable Quarter on the Trot
Golden Matrix Group is a gaming technology and e-sports company, operating its own gaming IP alongside providing white-label gaming platforms for third-parties Golden Matrix reports Revenues of $8,877,105 & net income of $349,379 in the…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space
InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company currently developing a pipeline of cannabinoid-based pharmaceutical drug candidates to treat several diseases with high, unmet medical needs. The company’s focus is on rare cannabinoids, many of…
-
MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Plans to Report Q1 2022 Results on May 16
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has announced its intention to release its first quarter 2022 financial results after market close on Monday, May 16, 2022. As part of that release…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Bridge Divide Between Cutting-Edge Science and Automotive Industry
Cepton (NASDAQ: CPTN) recently became a sponsor and an exclusive LiDAR provider for ten universities in North America gathered in a four-year STEM education program called The AutoDrive Challenge(TM) II. The program is designed to…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-Nicotine Pouch Performance to Be Compared to That of Leading Brands
Lexaria Bioscience Corp. (NASDAQ: LEXX) is expected to begin dosing for the NIC-H22-1 human study this summer. “NIC-H22-1, a pharmacokinetic randomized, double-blinded, cross-over study involving 36 human participants, will compare Lexaria’s DehydraTECH-nicotine pouch performance to…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Building on Growth Momentum to Bring Cutting-Edge Solutions
SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. The company appears poised to build upon its growth momentum to expand…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Executing Aggressive Growth Strategy
EverGen (TSX.V: EVGN) (OTCQB: EVGIF) is focused on combatting climate change and contributing to a sustainable future as an independent renewable energy producer that acquires, develops, builds, owns, and operates a portfolio of renewable natural…
-
MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding into Live Resin Vapes Segment to Capitalize on Growing Market
Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) recently announced the rollout of Platinum Vape(TM) (“PV”) Live Resin in Michigan, fulfilling its promise to introduce a steady stream of new products and consumption options to…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Webcast to Discuss 2021 Financial and Operating Results
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it will host a webcast at 9 a.m. ET on Tuesday, May 10, to discuss financial and…
-
Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial
Cybin has selected Clinilabs Drug Development Corporation as CRO for its Phase 1/2a clinical trial evaluating CYB003 for treating major depressive disorder (“MDD”) MDD impacts more than 264 million people worldwide, is a leading cause…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical cancer drug developer, recently reported new advances in its rollout of a global clinical trial described as “potentially pivotal” in producing a treatment for an aggressive brain cancer, glioblastoma…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Enters New Shopping Center Contract in Yonkers, New York
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that it has executed a new contract with a New York shopping center owner. The announcement reads,…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Readying Human Study to Compare Lexaria’s DehydraTECH-Nicotine Pouch Performance to that of Existing Leading Brands
In its most recent oral nicotine study, Lexaria established that DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls and peak levels achieved were up to 10x higher than controls Lexaria hopes…
-
MissionIRNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Preclinical Study Findings to Be Showcased at Global Event Focused on Psychedelic-Assisted Therapy
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that an abstract highlighting preclinical data for its deuterated psilocybin analog CYB003 has been selected for a poster…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) to Show High-Performance FIVE RS during Roadshow Tour
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that it will be adding its Mullen FIVE RS model to its summer roadshow tour. The company has been touring the country in…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science
InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science…
-
MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Roadshow Takes the Stage in Columbus, Ohio
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, recently announced that its Robot Roadshow will land at the Ohio Hotel & Lodging Association (“OHLA”) meeting taking place…
-
MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Partnership with IBN for Corporate Communications Needs
Golden Matrix Group (NASDAQ: GMGI), an established gaming technology company that develops and owns online gaming IP and builds turnkey online casino solutions for gaming operators, has selected InvestorBrandNetwork (“IBN”) for its corporate communications needs.…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters First UST Early Access Manufacturing Agreement
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, has signed…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Launches New Skincare Line Ahead of Luxury Meets Cannabis Conference
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the launch of a new skincare line under its brand, MIND Naturals (“Mind”), ahead of the Luxury Meets…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Transition from Pure-Play Pharma R&D Firm Featured in Research Report
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, was featured in a report published by Edison Group, a leading research and investor relations consultancy. The piece details…
-
Knightscope, Inc. (NASDAQ: KSCP) Autonomous Security Robot Adoption Plan Makes Round-the-Clock Surveillance Doable
Municipal governments as well as private business operations are looking for suitable solutions for preventing crime in order to stem the rising tide of violence in the nation Autonomous Security Robot (“ASR”) developer Knightscope is…
-
MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Launch of Physician-Focused Ads as Part of Large-Scale Campaign Around sugarBEAT(R)
Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company today announced that its U.K. licensee, MySugarWatch, as part of…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Plans Test Drive Tour Showcasing Mullen FIVE EV Crossover
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released the dates and schedule for its national test drive tour featuring its Mullen FIVE EV Crossover. According to the announcement, the company has…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Update on its Patented DehydraTECH(TM) Technology, Including the Approval of New Patent
Lexaria received its 25th patent – and the first patent for the use of DehydraTECH technology in the enhanced delivery of antiviral drugs The company is seeking IND approval from the FDA and has commenced…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces ‘Milestone’ Filing of Loan Application for Mullen ONE EV Cargo Van Program
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has filed an ATVM loan application with the U.S. Department of Energy (“DOE”). The loan is for the company’s ONE EV Cargo Van Program. According…
-
Golden Matrix Group Inc. (NASDAQ: GMGI) Is ‘One to Watch’
Golden Matrix’s common stock began trading on the Nasdaq on March 17, 2022 The company achieved record revenues of $8.88 million in the quarter ended January 31, 2022, marking a year-over-year increase of 355% Golden…
-
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strengthens Financial Profile with Debt Reduction, Adjustments to Revenue Strategy
Red White & Bloom Brands is a multi-state cannabis operator based in Canada and focused on developing revenue opportunities in strong U.S. cannabis markets such as Michigan, Florida and California The company recently announced it…
-
Knightscope, Inc. (NASDAQ: KSCP) Helping Companies Secure Critical Infrastructure, Reduce Security Threats
Knightscope develops Autonomous Security Robots (“ASRs”) that combine artificial intelligence (“AI”), robotics, and self-driving technology The company’s ASRs are used by clients operating in various industries, including critical infrastructure sectors such as public utilities, food…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Stands Distinct in REE Processing, Production Capabilities
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company that is also moving faster than any other company to re-establish a domestic rare earth elements (“REE”) supply chain, appears set to…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Creating Energy Resources While Solving Growing Waste Problem
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, uses innovative systems to capture and process into RNG (energy) harmful greenhouse gases that would otherwise…
-
MissionIRNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Schedules Release of Q1 2022 Financial Report, Conference Call
Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, announced that it anticipates releasing its 2022 first-quarter financial results on May 11, 2022; the company will also…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Participate in Luxury Meets Cannabis Conference
Flora Growth’s (NASDAQ: FLGC) executives Luis Merchan and James Choe are scheduled to participate at the upcoming Luxury Meets Cannabis Conference. The two-day event is scheduled for May 5–6, 2022, in New York City. The…
-
Tingo Inc. (TMNA) Pioneers an ESG Approach Within the African Continent
Women in Africa have often suffered from severe gender disparity; over a third of Africa’s female rural population have never accessed formal education with less than 24% having access to the Internet via a mobile…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands its Patent Portfolio With New Patent for Antiviral Drug Delivery with DehydraTECH
Lexaria just received another patent for DehydraTECH(TM): this time for the enhanced delivery of antiviral drugs This becomes the company’s 25th patent granted worldwide and the 10th granted in the U.S. It adds to the…
-
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Extends Michigan Expansion with Debut of Platinum Vape Live Resin; Announces Plans to Release Full-Year 2021 Results on May 2
Red White & Bloom and its wholly owned subsidiary RWB Michigan LLC recently announced the rollout of Platinum Vape(TM) Live Resin in Michigan The debut marks the company’s entry into the live resin in Michigan,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform
Lexaria Bioscience Corp. (NASDAQ: LEXX) is aware of the need to continuously improve its understanding of the capabilities and potential applications of its patented DehydraTECH(TM) drug delivery technology. This informs its long-held commitment to its…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Advancing Pipeline in Commitment to Transform Mental Health Treatment Landscape
Cybin (NYSE American: CYBN) (NEO: CYBN) is a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions in a commitment to transform the mental health treatment landscape. Through its…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”). The company today announced its receipt of…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioned to Power the Future of Clean Energy
- MissionIRNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology
- Silvercorp Metals, Inc. (NYSE-A/TSX: SVM) Reports Solid Production and Revenue in Q1 FY2026
- Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
- Massimo Group (NASDAQ: MAMO) Accelerates Golf Cart Market Reach with Vietnam Partnership